The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial | MicrobiomeTrials← Back to trialsNCT05650645
The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2023-01-01Est. Completion: 2025-12-29
Enrollment target: 41 participants Locations- University of Minnesota, Minneapolis, Minnesota, United States
Other microbiome trials you might be interested in
Tinnitus
Tinnitus affects 10-15% of adults and is frequently associated with impaired quality of life, anxiety, and sleep disturb…
Shanghai, ChinaCompleted Feb 11, 2026
Hearing Loss, BinauralCochlear Implantation
This Post-Market Clinical Follow-up (PMCF) investigation aims to further collect evidence on safety and performance of t…
Multiple LocationsEst. completion Dec 2028